Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Vismodegib
Drug ID BADD_D02365
Description Vismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012.
Indications and Usage Vismodegib is used for treating locally advanced or metastatic basal cell carcinoma in patients whose carcinoma has recurred after surgery, and in patients who are not candidates for surgery or radiation.
Marketing Status Prescription
ATC Code L01XJ01
DrugBank ID DB08828
KEGG ID D09992
MeSH ID C538724
PubChem ID 24776445
TTD Drug ID D03EDQ
NDC Product Code 50242-140
Synonyms HhAntag691 | NSC 747691 | NSC747691 | NSC-747691 | R 3616 | R3616 cpd | R-3616 | vismodegib | erivedge | GDC 0449 | GDC0449 | GDC-0449 | RG 3616 | RG3616 | RG-3616
Chemical Information
Molecular Formula C19H14Cl2N2O3S
CAS Registry Number 879085-55-9
SMILES CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bacteraemia11.01.11.0010.000533%
Basal cell carcinoma16.03.02.001; 23.08.02.0010.015185%Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Blood creatine phosphokinase increased13.04.01.0010.003197%
Blood creatinine abnormal13.13.01.0020.000533%Not Available
Blood creatinine increased13.13.01.0040.003730%
Blood glucose decreased13.02.02.0010.000533%Not Available
Blood glucose increased13.02.02.0020.001332%Not Available
Blood potassium decreased13.11.01.0100.000533%Not Available
Blood potassium increased13.11.01.0110.000799%Not Available
Blood pressure decreased13.14.03.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Blood sodium decreased13.11.01.0120.000533%Not Available
Blood urea increased13.13.01.0060.000533%Not Available
Bone pain15.02.01.001--
Breast pain21.05.05.0030.000533%
Bronchitis22.07.01.001; 11.01.09.001--
Cachexia16.32.03.011; 14.03.02.001; 08.01.01.0090.000208%Not Available
Cardiac failure02.05.01.001--
Cardiac failure congestive02.05.01.002--Not Available
Cellulitis23.09.01.001; 11.02.01.001--Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Cholelithiasis09.03.01.0020.000533%Not Available
Cholestasis09.01.01.0010.001066%Not Available
Chromaturia20.02.01.0020.000533%
Colitis07.08.01.0010.000799%
Colon cancer16.13.01.001; 07.21.01.0010.000139%Not Available
Confusional state19.13.01.001; 17.02.03.005--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 12 Pages